Adline Chem Lab Complete Financial Statements
In FYNone, Adline Chem Lab (ADLINE) reported revenue ₹0 Cr, net profit ₹0 Cr and EPS ₹0.00, with a net profit margin of -400.0%. Full financial statements from FY2015 to FY2025 (11 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Review ADLINE earnings multiple to evaluate earnings-based valuation against sector peers.
Complete Financial Data Export
Profitability Ratios
Balance Sheet Ratios
ADLINE Revenue, Net Profit & EBITDA — Year-on-Year Growth
ADLINE YoY (March 2025 vs Period). Explore ADLINE value investing to estimate fundamental worth using multiple valuation models.
ADLINE Income Statement — Revenue, EBITDA & Net Profit
Adline Chem Lab revenue ₹0 Cr, EBITDA ₹0 Cr, net profit ₹0 Cr, EPS ₹0.00 (None) — net profit margin -400.0%. For live price, earnings ratios and company overview, see Adline Chem Lab share price today.
| Particulars | None | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 1 | 1 | 6 | 7 | 6 | 8 | 17 | 17 | 15 |
| Expenses | 0 | 0 | 0 | 1 | 1 | 7 | 10 | 5 | 7 | 16 | 17 | 14 |
| EBITDA | 0 | 0 | 0 | 0 | 0 | 0 | -3 | 1 | 1 | 1 | 1 | 1 |
| Operating Profit Margin % | 0.00% | 0.00% | 0.00% | 0.00% | -40.00% | -4.00% | -51.00% | 11.00% | 11.00% | 7.00% | 3.00% | 6.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 0 | 1 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Profit Before Tax | 0 | 0 | 0 | -4 | 1 | -1 | -4 | 0 | 0 | 0 | 0 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 0 | 0 | 0 | -4 | 1 | -1 | -4 | 0 | 0 | 0 | 0 | 0 |
| Earnings Per Share (₹) | 0.00 | -0.21 | -0.46 | -7.24 | 1.23 | -2.19 | -6.45 | 0.05 | 0.00 | 0.01 | 0.02 | 0.04 |
ADLINE Balance Sheet — Assets, Liabilities & Shareholders' Equity
ADLINE total assets ₹0 Cr, total equity ₹-2 Cr, total liabilities ₹0 Cr (2025).
| Particulars | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Total Assets | 0 | 0 | 0 | 5 | 6 | 8 | 22 | 23 | 21 | 18 | 19 |
| Current Assets | 0 | 0 | 0 | 0 | 2 | 3 | 10 | 11 | 8 | 7 | 7 |
| Fixed Assets | 0 | 0 | 0 | 4 | 4 | 5 | 12 | 13 | 13 | 10 | 10 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 0 | 0 | 0 | 0 | 2 | 3 | 10 | 11 | 8 | 8 | 8 |
| LIABILITIES | |||||||||||
| Total Liabilities | 0 | 0 | 0 | 5 | 6 | 8 | 22 | 23 | 21 | 18 | 19 |
| Current Liabilities | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 4 | 5 | 6 |
| Non-Current Liabilities | |||||||||||
| SHAREHOLDERS' EQUITY | |||||||||||
| Total Equity | -2 | -1 | -2 | 3 | 2 | 3 | 7 | 7 | 7 | 7 | 7 |
| Share Capital | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 |
| Reserves & Surplus | -7 | -7 | -7 | -3 | -4 | -3 | 1 | 1 | 1 | 1 | 1 |
ADLINE Cash Flow Statement — Operating, Investing & Financing
Adline Chem Lab operating cash flow ₹0 Cr, investing ₹0 Cr, financing ₹0 Cr, net cash flow ₹0 Cr (2025).
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 0 | 0 | 0 | 0 | 0 | -11 | -1 | 1 | 3 | 1 | 0 |
| Investing Activities | 0 | 0 | 0 | 0 | 0 | 11 | 0 | 0 | -3 | 0 | -2 |
| Financing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | -1 | 2 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 | -2 | 2 | 0 | 0 | 0 |